Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades

Analysts at SunTrust Robinson Humphrey upgraded Exelon Corporation (NYSE: EXC) from Neutral to Buy. The price target for Exelon has been raised from $30 to $33. Exelon shares closed at $29.70 on Friday.

Barrington Research upgraded USA Technologies, Inc. (NASDAQ: USAT) to Outperform. USA Technologies shares closed at $2.88 on Friday.

Analysts at KeyBanc upgraded Biomed Realty Trust Inc (NYSE: BMR) to Overweight. BioMed Realty Trust shares closed at $18.91 on Friday.

Citigroup upgraded Mack Cali Realty Corp (NYSE: CLI) from Neutral to Buy. The price target for Mack-Cali Realty has been raised from $22 to $24. Mack-Cali Realty shares closed at $19.64 on Friday.

Analysts at Deutsche Bank upgraded AstraZeneca plc (ADR) (NYSE: AZN) from Hold to Buy. AstraZeneca shares closed at $33.30 on Friday.

Analysts at Goldman Sachs upgraded Xilinx, Inc. (NASDAQ: XLNX) from Neutral to Buy. The price target for Xilinx has been raised from $41 to $50. Xilinx shares closed at $41.93 on Friday.

Analysts at Macquarie upgraded Oppenheimer Holdings Inc. (USA) (NYSE: OPY) from Neutral to Outperform. The price target for Oppenheimer Holdings has been raised from $25 to $27. Oppenheimer Holdings shares closed at $17.98 on Friday.

Barclays upgraded Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) from Equal-weight to Overweight. The price target for Vertex Pharmaceuticals has been raised from $120 to $150. Vertex Pharmaceuticals shares closed at $134.06 on Friday.

Citigroup upgraded Ingredion Inc (NYSE: INGR) from Neutral to Buy. The price target for Ingredion has been raised from $90 to $100. Ingredion shares closed at $83.29 on Friday.

KeyBanc upgraded Taubman Centers, Inc. (NYSE: TCO) to Overweight. Taubman Centers shares closed at $68.26 on Friday.

Latest Ratings for EXC

DateFirmActionFromTo
Oct 2019MaintainsOutperform
Oct 2019MaintainsNeutral
Sep 2019MaintainsBuy

View More Analyst Ratings for EXC
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (AZN + BMR)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
IPARDA DavidsonMaintains76.0
BSBRUBSUpgrades
TGTMorgan StanleyMaintains130.0
VCMorgan StanleyMaintains52.0
URBNMorgan StanleyMaintains32.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Cellular Biomedicine Group to Release CAR-T for Non-Small Cell Lung Cancer Phase I Clinical Trial Data at 2015 European Cancer Congress

Bob Peck: Barron's Is Wrong, Alibaba Worth $100